Concepedia

Karen Ingraham

KI

20

Publications

1.8K

Citations

18

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

South College

Research Triangle Park Foundation

Target (United States)

Karen Ingraham is an author at GlaxoSmithKline (United States) specializing in medicine, drug resistance, and microbiology.

Top concepts

Publications per year

2000–2020

20

Publications

20

A genomic analysis of two‐component signal transduction in <i>Streptococcus pneumoniae</i>

John Throup, Kristin K. Koretke, Alexander P. Bryant et al. · Molecular Microbiology · 2000 · 318 citations

Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci

E. Imogen Wilding, James R. Brown, Alexander P. Bryant et al. · Journal of Bacteriology · 2000 · 261 citations · Full text

Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin

Pan F. Chan, Srikannathasan Velupillai, Jianzhong Huang et al. · Nature Communications · 2015 · 153 citations · Full text

Comparative Genomics of Klebsiella pneumoniae Strains with Different Antibiotic Resistance Profiles

Vinod Kumar, Peng Sun, Jessica Vamathevan et al. · Antimicrobial Agents and Chemotherapy · 2011 · 105 citations · Full text

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

Karen O’Dwyer, Aaron Spivak, Karen Ingraham et al. · Antimicrobial Agents and Chemotherapy · 2014 · 97 citations · Full text

, , +21

Rows per page

1–5 of 20